Detection of Minority Variants and Mixed Infections in Mycobacterium tuberculosis by Direct Whole-Genome Sequencing on Noncultured Specimens Using a Specific-DNA Capture Strategy.


Journal

mSphere
ISSN: 2379-5042
Titre abrégé: mSphere
Pays: United States
ID NLM: 101674533

Informations de publication

Date de publication:
22 12 2021
Historique:
pubmed: 16 12 2021
medline: 12 2 2022
entrez: 15 12 2021
Statut: ppublish

Résumé

Detection of mixed Mycobacterium tuberculosis (MTB) infections is essential, particularly when resistance mutations are present in minority bacterial populations that may affect patients' disease evolution and treatment. Whole-genome sequencing (WGS) has extended the amount of key information available for the diagnosis of MTB infection, including the identification of mixed infections. Having genomic information at diagnosis for early intervention requires carrying out WGS directly on the clinical samples. However, few studies have been successful with this approach due to the low representation of MTB DNA in sputa. In this study, we evaluated the ability of a strategy based on specific MTB DNA enrichment by using a newly designed capture platform (MycoCap) to detect minority variants and mixed infections by WGS on controlled mixtures of MTB DNAs in a simulated sputum genetic background. A pilot study was carried out with 12 samples containing 98% of a DNA pool from sputa of patients without MTB infection and 2% of MTB DNA mixtures at different proportions. Our strategy allowed us to generate sequences with a quality equivalent to those obtained from culture: 62.5× depth coverage and 95% breadth coverage (for at least 20× reads). Assessment of minority variant detection was carried out by manual analysis and allowed us to identify heterozygous positions up to a 95:5 ratio. The strategy also automatically distinguished mixed infections up to a 90:10 proportion. Our strategy efficiently captures MTB DNA in a nonspecific genetic background, allows detection of minority variants and mixed infections, and is a promising tool for performing WGS directly on clinical samples.

Identifiants

pubmed: 34908457
doi: 10.1128/mSphere.00744-21
pmc: PMC8673255
doi:

Substances chimiques

DNA, Bacterial 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0074421

Références

Hereditas. 2021 Feb 17;158(1):10
pubmed: 33597004
J Infect Dis. 2016 Jun 1;213(11):1796-9
pubmed: 26768249
J Clin Microbiol. 2017 Feb;55(2):457-469
pubmed: 27903602
PLoS One. 2020 Dec 31;15(12):e0244829
pubmed: 33382836
Tuberculosis (Edinb). 2017 Dec;107:168-174
pubmed: 29050766
PLoS One. 2015 May 13;10(5):e0126626
pubmed: 25970423
J Clin Microbiol. 2011 Jan;49(1):385-8
pubmed: 20980576
Front Genet. 2019 Jun 04;10:477
pubmed: 31214242
Eur Respir J. 2021 Mar 18;57(3):
pubmed: 32943401
BMC Genomics. 2019 May 20;20(1):389
pubmed: 31109296
J Clin Microbiol. 2010 Jul;48(7):2495-501
pubmed: 20504986
PLoS One. 2017 May 18;12(5):e0176522
pubmed: 28545050
BMC Genomics. 2018 Aug 14;19(1):613
pubmed: 30107785
J Clin Microbiol. 2013 May;51(5):1596-9
pubmed: 23447641
J Infect Dis. 2018 Nov 5;218(12):1974-1982
pubmed: 30085153
J Infect Dis. 2016 Oct 15;214(8):1286-7
pubmed: 27493236
Clin Chem. 2020 Oct 1;66(10):1278-1289
pubmed: 32918462
J Clin Microbiol. 2014 Jul;52(7):2422-9
pubmed: 24789181
J Clin Microbiol. 2017 May;55(5):1285-1298
pubmed: 28275074
Int J Tuberc Lung Dis. 2016 Mar;20(3):423-4
pubmed: 27046727
Infect Genet Evol. 2017 Mar;48:76-82
pubmed: 27998730
Euro Surveill. 2021 Jan;26(2):
pubmed: 33446303
Int J Infect Dis. 2017 Sep;62:44-46
pubmed: 28716462
J Clin Microbiol. 2019 Oct 23;57(11):
pubmed: 31413081
Nucleic Acids Res. 2012 Dec;40(22):11189-201
pubmed: 23066108
BMC Infect Dis. 2012 Jan 20;12:9
pubmed: 22260344
Int J Infect Dis. 2021 Dec;113 Suppl 1:S40-S42
pubmed: 33716192
Tuberculosis (Edinb). 2010 May;90(3):201-7
pubmed: 20435520
Bioinformatics. 2020 Feb 15;36(4):985-989
pubmed: 31580405
J Clin Microbiol. 2018 Jul 26;56(8):
pubmed: 29848567
J Clin Microbiol. 2015 Jul;53(7):2138-47
pubmed: 25903578

Auteurs

Nuria Lozano (N)

Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.
Servicio de Microbiología Clínica y Enfermedades Infecciosas, Hospital General Universitario Gregorio Marañóngrid.410526.4, Madrid, Spain.

Val F Lanza (VF)

Bioinformatics Unit IRYCIS, University Hospital Ramón y Cajal, Madrid, Spain.
CIBER Enfermedades Infecciosas, Madrid, Spain.

Julia Suárez-González (J)

Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.
Unidad de Genómica, Hospital General Universitario Gregorio Marañóngrid.410526.4, Madrid, Spain.

Marta Herranz (M)

Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.
Servicio de Microbiología Clínica y Enfermedades Infecciosas, Hospital General Universitario Gregorio Marañóngrid.410526.4, Madrid, Spain.
CIBER Enfermedades Respiratorias, CIBERES, Madrid, Spain.

Pedro J Sola-Campoy (PJ)

Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.
Servicio de Microbiología Clínica y Enfermedades Infecciosas, Hospital General Universitario Gregorio Marañóngrid.410526.4, Madrid, Spain.

Cristina Rodríguez-Grande (C)

Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.
Servicio de Microbiología Clínica y Enfermedades Infecciosas, Hospital General Universitario Gregorio Marañóngrid.410526.4, Madrid, Spain.

Sergio Buenestado-Serrano (S)

Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.
Servicio de Microbiología Clínica y Enfermedades Infecciosas, Hospital General Universitario Gregorio Marañóngrid.410526.4, Madrid, Spain.

María Jesús Ruiz-Serrano (MJ)

Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.
Servicio de Microbiología Clínica y Enfermedades Infecciosas, Hospital General Universitario Gregorio Marañóngrid.410526.4, Madrid, Spain.

Griselda Tudó (G)

Servei de Microbiologia, Hospital Clinic-CDB, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Barcelona, Spain.

Fernando Alcaide (F)

Servicio de Microbiología, Hospital Universitario de Bellvitge-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.
Department of Pathology and Experimental Therapy, University of Barcelona, L'Hospitalet de Llobregat, Barcelona, Spain.

Patricia Muñoz (P)

Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.
Servicio de Microbiología Clínica y Enfermedades Infecciosas, Hospital General Universitario Gregorio Marañóngrid.410526.4, Madrid, Spain.
CIBER Enfermedades Respiratorias, CIBERES, Madrid, Spain.
Departmento de Medicina, Universidad Complutense de Madrid, Madrid, Spain.

Darío García de Viedma (D)

Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.
Servicio de Microbiología Clínica y Enfermedades Infecciosas, Hospital General Universitario Gregorio Marañóngrid.410526.4, Madrid, Spain.
CIBER Enfermedades Respiratorias, CIBERES, Madrid, Spain.

Laura Pérez-Lago (L)

Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.
Servicio de Microbiología Clínica y Enfermedades Infecciosas, Hospital General Universitario Gregorio Marañóngrid.410526.4, Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH